Vanguard Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$167M Sell
432,196
-13,994
-3% -$5.19M 0.11% 150
2026
Q1
$131M Buy
+446,190
New +$147M 0.11% 180

Other funds holding ELV

Vanguard Asset Management's ELV Position: Q2 2026 in Review

Vanguard Asset Management reduced its Elevance Health (ELV) stake by 3.1% in Q2 2026, selling an estimated $5.19M and leaving 432,196 shares worth $167M. The position accounts for 0.11% of the portfolio, ranked #150.

Vanguard Asset Management first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vanguard Asset Management held 432,196 shares of Elevance Health worth $167M as of Q2 2026.
  • Vanguard Asset Management sold 13,994 Elevance Health shares in Q2 2026, an estimated $5.19M.
  • Elevance Health made up 0.11% of Vanguard Asset Management's portfolio in Q2 2026, its #150 holding.
  • Vanguard Asset Management first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
  • 1,513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.